Gastric carcinoma (GC) represents one of the most common and most lethal malignancies
worldwide. The histopathological characterization of GC precursor lesions has provided …

Over the last two decades there has been a broad paradigm shift in our understanding of
gastric cancer (GC) and its premalignant states from gross histological models to …

Intestinal‐type gastric cancer (IGC) has a clear and multistep histological evolution. No
studies have comprehensively explored gastric tumorigenesis from inflammation through …

Prognosis of gastric cancer is dramatically improved by early diagnosis. Correa's cascade
correlates the expression of some molecular markers with the progression of preneoplastic …

Gastric cancer (GC) is one of the most frequently diagnosed cancers worldwide and its
prognosis remains dismal. One reason for poor outcomes of GC patients is that most are …

Currently, gastric cancer (GC) is one of the most frequently diagnosed neoplasms, with a
global burden of 723000 deaths in 2012. It is the third leading cause of cancer-related death …

Gastric cancer (GC) is a heterogeneous disease, often diagnosed at advanced stages, with
a 5-year survival rate of approximately 20%. Despite notable technological advancements in …

Gastric cancer is in decline in most developed countries; however, it still accounts for a
notable fraction of global mortality and morbidity related to cancer. High-throughput methods …

Gastric cancer (GC) is one of the most common lethal malignant neoplasms worldwide, with
limited treatment options for both locally advanced and/or metastatic conditions, resulting in …

Gastric cancer is the fourth most common malignancy and the second most frequent cause
of cancer-related death in the world. It is often diagnosed in advanced stages when …